Cvs Health Operating Expenses Growth & History (CVS)
Cvs Health's operating expenses was $397.41B for fiscal 2025.
View full Cvs Health company overviewCvs Health annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $397.41B | $33.11B | +9.09% |
| 2024 | 2024-12-31 | $364.29B | $20.26B | +5.89% |
| 2023 | 2023-12-31 | $344.03B | $29.52B | +9.39% |
| 2022 | 2022-12-31 | $314.51B | $35.71B | +12.81% |
| 2021 | 2021-12-31 | $278.80B | $24.01B | +9.42% |
| 2020 | 2020-12-31 | $254.79B | $10.01B | +4.09% |
| 2019 | 2019-12-31 | $244.79B | $54.23B | +28.46% |
| 2018 | 2018-12-31 | $190.56B | $15.31B | +8.74% |
| 2017 | 2017-12-31 | $175.25B | $8.09B | +4.84% |
| 2016 | 2016-12-31 | $167.16B | $150.11B | +880.24% |
| 2015 | 2015-12-31 | $17.05B | $485.0M | +2.93% |
| 2014 | 2014-12-31 | $16.57B | $822.0M | +5.22% |
| 2013 | 2013-12-31 | $15.75B | $468.0M | +3.06% |
| 2012 | 2012-12-31 | $15.28B | $1.05B | +7.36% |
| 2011 | 2011-12-31 | $14.23B | $149.0M | +1.06% |
| 2010 | 2010-12-31 | $14.08B | $149.0M | +1.07% |
| 2009 | 2009-12-31 | $13.93B | $1.69B | +13.79% |
| 2008 | 2008-12-31 | $12.24B | $930.0M | +8.22% |
| 2007 | 2007-12-29 | $11.31B | — | — |
Cvs Health quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $101.39B | $4.86B | +5.03% |
| Q1 2026 | 2026-03-31 | $95.75B | $4.53B | +4.97% |
| Q4 2025 | 2025-12-31 | $103.58B | $8.24B | +8.64% |
| Q3 2025 | 2025-09-30 | $106.08B | $11.48B | +12.14% |
| Q2 2025 | 2025-06-30 | $96.53B | $8.35B | +9.46% |
| Q1 2025 | 2025-03-31 | $91.21B | $5.05B | +5.86% |
| Q4 2024 | 2024-12-31 | $95.34B | $4.90B | +5.42% |
| Q3 2024 | 2024-09-30 | $94.60B | $8.52B | +9.90% |
| Q2 2024 | 2024-06-30 | $88.19B | $2.50B | +2.92% |
| Q1 2024 | 2024-03-31 | $86.17B | $4.33B | +5.30% |
| Q4 2023 | 2023-12-31 | $90.44B | $10.25B | +12.79% |
| Q3 2023 | 2023-09-30 | $86.07B | $996.0M | +1.17% |
| Q2 2023 | 2023-06-30 | $85.69B | $9.72B | +12.80% |
| Q1 2023 | 2023-03-31 | $81.83B | $8.55B | +11.67% |
| Q4 2022 | 2022-12-31 | $80.19B | $5.93B | +7.98% |
| Q3 2022 | 2022-09-30 | $85.08B | $14.35B | +20.28% |
| Q2 2022 | 2022-06-30 | $75.97B | $7.68B | +11.24% |
| Q1 2022 | 2022-03-31 | $73.28B | $7.76B | +11.85% |
| Q4 2021 | 2021-12-31 | $74.26B | $7.23B | +10.78% |
| Q3 2021 | 2021-09-30 | $70.73B | $6.93B | +10.85% |
| Q2 2021 | 2021-06-30 | $68.29B | $7.63B | +12.58% |
| Q1 2021 | 2021-03-31 | $65.52B | $2.22B | +3.51% |
| Q4 2020 | 2020-12-31 | $67.03B | $3.18B | +4.98% |
| Q3 2020 | 2020-09-30 | $63.81B | $1.93B | +3.11% |
| Q2 2020 | 2020-06-30 | $60.66B | $562.0M | +0.94% |
| Q1 2020 | 2020-03-31 | $63.30B | $4.34B | +7.36% |
| Q4 2019 | 2019-12-31 | $63.85B | $10.25B | +19.13% |
| Q3 2019 | 2019-09-30 | $61.88B | $16.97B | +37.77% |
| Q2 2019 | 2019-06-30 | $60.10B | $11.80B | +24.44% |
| Q1 2019 | 2019-03-31 | $58.96B | $15.21B | +34.77% |
| Q4 2018 | 2018-12-31 | $53.60B | −$107.44B | −66.72% |
| Q3 2018 | 2018-09-30 | $44.92B | $40.30B | +872.63% |
| Q2 2018 | 2018-06-30 | $48.30B | $43.49B | +904.26% |
| Q1 2018 | 2018-03-31 | $43.75B | $38.97B | +815.59% |
| Q4 2017 | 2017-12-31 | $161.04B | $156.44B | +3396.37% |
| Q3 2017 | 2017-09-30 | $4.62B | −$50.0M | −1.07% |
| Q2 2017 | 2017-06-30 | $4.81B | $151.0M | +3.24% |
| Q1 2017 | 2017-03-31 | $4.78B | $219.0M | +4.80% |
| Q4 2016 | 2016-12-31 | $4.61B | $34.0M | +0.74% |
| Q3 2016 | 2016-09-30 | $4.67B | $338.0M | +7.81% |
| Q2 2016 | 2016-06-30 | $4.66B | $518.0M | +12.51% |
| Q1 2016 | 2016-03-31 | $4.56B | $527.0M | +13.07% |
| Q4 2015 | 2015-12-31 | $4.57B | $260.0M | +6.03% |
| Q3 2015 | 2015-09-30 | $4.33B | $108.0M | +2.56% |
| Q2 2015 | 2015-06-30 | $4.14B | $24.0M | +0.58% |
| Q1 2015 | 2015-03-31 | $4.03B | $114.0M | +2.91% |
| Q4 2014 | 2014-12-31 | $4.31B | $191.0M | +4.63% |
| Q3 2014 | 2014-09-30 | $4.22B | $349.0M | +9.01% |
| Q2 2014 | 2014-06-30 | $4.12B | $247.0M | +6.38% |
| Q1 2014 | 2014-03-31 | $3.92B | $35.0M | +0.90% |
| Q4 2013 | 2013-12-31 | $4.12B | $126.0M | +3.15% |
| Q3 2013 | 2013-09-30 | $3.87B | $40.0M | +1.04% |
| Q2 2013 | 2013-06-30 | $3.87B | $128.0M | +3.42% |
| Q1 2013 | 2013-03-31 | $3.88B | $174.0M | +4.69% |
| Q4 2012 | 2012-12-31 | $4.00B | $397.0M | +11.03% |
| Q3 2012 | 2012-09-30 | $3.83B | $239.0M | +6.65% |
| Q2 2012 | 2012-06-30 | $3.74B | $139.0M | +3.86% |
| Q1 2012 | 2012-03-31 | $3.71B | $272.0M | +7.91% |
| Q4 2011 | 2011-12-31 | $3.60B | −$95.0M | −2.57% |
| Q3 2011 | 2011-09-30 | $3.59B | $57.0M | +1.61% |
| Q2 2011 | 2011-06-30 | $3.60B | $83.0M | +2.36% |
| Q1 2011 | 2011-03-31 | $3.44B | $101.0M | +3.03% |
| Q4 2010 | 2010-12-31 | $3.69B | $20.0M | +0.54% |
| Q3 2010 | 2010-09-30 | $3.54B | $91.0M | +2.64% |
| Q2 2010 | 2010-06-30 | $3.52B | $67.0M | +1.94% |
| Q1 2010 | 2010-03-31 | $3.34B | −$35.0M | −1.04% |
| Q4 2009 | 2009-12-31 | $3.67B | — | — |
| Q3 2009 | 2009-09-30 | $3.45B | $511.6M | +17.43% |
| Q2 2009 | 2009-06-30 | $3.45B | $556.9M | +19.24% |
| Q1 2009 | 2009-03-31 | $3.37B | — | — |
| Q3 2008 | 2008-09-27 | $2.93B | — | — |
| Q2 2008 | 2008-06-28 | $2.90B | — | — |
Cvs Health operating expenses trends
Over the last five fiscal years, Cvs Health's operating expenses increased from $254.79B to $397.41B, a change of $142.61B. The latest reported quarter, Q2 2026, shows $101.39B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cvs Health source filings ↗